Hang Thi Thu. Nguyen, et.al., CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice., The Journal of clinical investigation, 2011, 121

http://rdf.ncbi.nlm.nih.gov/pubmed/21490400

Hang Thi Thu. Nguyen, et.al., CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice., The Journal of clinical investigation, 2011, 121

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Slc3a2<tm1.1Merl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5433604
• Tg(Vil-SLC3A2)HEMerl
  http://metadb.riken.jp/db/mgi_rdf/MGI:5433607

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal enterocyte morphology_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0000479IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• abnormal cecum morphology_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0000494IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• abnormal small intestine morphology_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0000496IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased body size_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0001265IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• increased colonic adenoma incidence_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0002044IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• colitis_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0002816IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
他19件を見る
• rectal hemorrhage_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0003293IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased tumor growth/size_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0003447B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• increased tumor growth/size_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0003721IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• increased incidence of tumors by chemical induction_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0004499IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased incidence of tumors by chemical induction_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0004502B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• diarrhea_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0005036IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased small intestinal microvillus size_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0008141IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• increased susceptibility to induced colitis_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0008537IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased susceptibility to induced colitis_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0008539B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• increased circulating tumor necrosis factor level_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0008553IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• abnormal enterocyte physiology_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0008882IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• abnormal enterocyte proliferation_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0008883B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• abnormal enterocyte proliferation_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0008883IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• increased sensitivity to xenobiotic induced morbidity/mortality_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0009766IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased sensitivity to xenobiotic induced morbidity/mortality_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0009767B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• abnormal intestine physiology_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0010155IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• increased susceptibility to weight loss_Tg(Vil-SLC3A2)HEMerl/0
  http://metadb.riken.jp/0010180IFVBNTgVilSLC3A2HEMerl0TgVilSLC3A2HEMerl
• decreased susceptibility to weight loss_Slc3a2<tm1.1Merl>/Slc3a2<+>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0010181B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2TgVil1cre997Gum0TgVil1cre997GumSlc3a2tm11MerlSlc3a2
• preweaning lethality, incomplete penetrance_Slc3a2<tm1.1Merl>/Slc3a2<tm1.1Merl>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0011110B6CgSlc3a2tm11MerlTgVil1cre997GumSlc3a2tm11MerlSlc3a2tm11MerlTgVil1cre997Gum0Slc3a2tm11MerlTgVil1cre997Gum

class

http://purl.org/net/cito/citesAsAuthority

• Slc3a2<tm1.1Merl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5433604
• Tg(Vil-SLC3A2)HEMerl
  http://metadb.riken.jp/db/mgi_rdf/MGI:5433607